| Nancy Marsden Bauer, RPH | |
|
2140 Us Highway 23 S., Alpena, MI 49707 | |
| (989) 354-4630 | |
| Not Available |
| Full Name | Nancy Marsden Bauer |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2140 Us Highway 23 S., Alpena, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437197225 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 5302022626 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nancy Marsden Bauer, RPH 2140 Us Highway 23 S., Alpena, MI 49707 Ph: (989) 354-4630 | Nancy Marsden Bauer, RPH 2140 Us Highway 23 S., Alpena, MI 49707 Ph: (989) 354-4630 |
News Archive
3D Signatures Inc. is pleased to announce that a preliminary third-party analysis of the trial data for Telo-HL, 3DS' test in development for Hodgkin's lymphoma (HL), shows that the Company's TeloViewTM platform is able to distinguish, with a high degree of statistical significance, multiple differences between a patient group that responds to standard ABVD chemotherapy, and a group that relapses or is refractory to treatment within the first 12 months.
Next week, advisers to the Food and Drug Administration will recommend whether the agency should approve the first new prescription diet pill in 13 years. The F.D.A. rejected the drug under review, Qnexa, in 2010, amid safety concerns, and the drug's manufacturer is now presenting additional data to argue its case.
Stanford Medicine scientists have linked insulin resistance to an increased risk of developing a major depressive disorder.
Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, announced today results from its Phase 2a clinical trial for its ORMD-0801 oral insulin capsule for the treatment of type 2 diabetes. The trial was conducted under a United States Food and Drug Administration IND (Investigational New Drug) protocol. The Phase 2a study met all primary and secondary endpoints.
› Verified 3 days ago
Mrs. Sherry Lynn Schaedig, ABOC 163492 Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1180 M 32 W, Alpena, MI 49707 Phone: 989-354-7431 Fax: 989-354-7532 | |
Dr. Chima Nwamba, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1180 M 32 W, Alpena, MI 49707 Phone: 989-354-0731 | |
Dr. Mitchell Gregory May, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1011 M 32 W, Alpena, MI 49707 Phone: 989-354-8784 | |
Keith Allan Misiak, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2236 Us Highway 23 S, Alpena, MI 49707 Phone: -- | |
Alex Senchuk, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1202 W Chisholm St, Alpena, MI 49707 Phone: 989-354-3189 | |
John P. Radocy, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2140 Us Highway 23 S, Alpena, MI 49707 Phone: 989-354-4630 | |
Dr. Sarah Elaine Nowakowski, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1185 Us Highway 23 N, Alpena, MI 49707 Phone: 989-358-3950 Fax: 989-358-3720 |